2027 NCODA Global Oncology & Haematology Congress
March 10, 2027 | 9:00 AM EST
- Home
- Clinical Resources Search
- Example SOPs and Documents: Bispecific T-Cell Engager Associated Cytokine Release Syndrome (CRS) Management
Bispecific T-Cell Engager Associated Cytokine Release Syndrome (CRS) Management
Last Updated: July 1, 2025
Bispecific T-Cell Engager Associated Cytokine Release Syndrome (CRS) Management (Mid-sized, Rural Community Cancer Clinic)
Find Similar Resources:
Immunotherapy
Immunotherapy
Immunotherapy
Immunotherapy
Overview of BTCEs: Comparison of Bispecific T-Cell Engagers (BTCEs)
Last Updated: 09/09/2026
Up Close with Linvoseltamab
Last Updated: 06/29/2026
Example SOPs and Documents: Transitioning Patients on Bispecific T-Cell Engagers Between Care Settings
Last Updated: 07/01/2025
Example SOPs and Documents: Bispecific T-cell Engager Billing Procedure
Last Updated: 07/01/2025
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Melphalan Conditioning for Autologous Transplant
Last Updated: 09/29/2026
Carmustine, Etoposide, Cytarabine, and Melphalan
Last Updated: 09/29/2026
Talquetamab, Pomalidomide and Daratumumab/Hyaluronidase
Last Updated: 09/29/2026
Talquetamab and Daratumumab/Hyaluronidase
Last Updated: 09/29/2026